Clinical trial
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
NCT00512876 is registered in ClinicalTrials.gov with Walter Reed Army Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
- Lead sponsor
- Walter Reed Army Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- January 31, 2011
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.